Skip to main content
Journal cover image

Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial.

Publication ,  Journal Article
Rodger, MA; Phillips, P; Kahn, SR; Bates, S; McDonald, S; Khurana, R; James, AH; Konkle, BA ...
Published in: Thromb Res
June 2016

Duke Scholars

Published In

Thromb Res

DOI

EISSN

1879-2472

Publication Date

June 2016

Volume

142

Start / End Page

17 / 20

Location

United States

Related Subject Headings

  • Venous Thromboembolism
  • Postpartum Period
  • Pilot Projects
  • Humans
  • Heparin, Low-Molecular-Weight
  • Female
  • Cardiovascular System & Hematology
  • Anticoagulants
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rodger, M. A., Phillips, P., Kahn, S. R., Bates, S., McDonald, S., Khurana, R., … PROSPER Investigators: Tim Ramsay, Dean Fergusson, Anne McLeod, Wee Shian Chan, Rshmi Khurana, Kara Narenberg, Haim Abenhaim, John Heit, Ghada Bourjeilly, Paul Gibson, Kent Bailey, . (2016). Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial. Thromb Res, 142, 17–20. https://doi.org/10.1016/j.thromres.2016.04.004
Rodger, Marc A., Penny Phillips, Susan R. Kahn, Shannon Bates, Sarah McDonald, Rshmi Khurana, Andra H. James, Barbara A. Konkle, and Barbara A. PROSPER Investigators: Tim Ramsay, Dean Fergusson, Anne McLeod, Wee Shian Chan, Rshmi Khurana, Kara Narenberg, Haim Abenhaim, John Heit, Ghada Bourjeilly, Paul Gibson, Kent Bailey. “Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial.Thromb Res 142 (June 2016): 17–20. https://doi.org/10.1016/j.thromres.2016.04.004.
Rodger MA, Phillips P, Kahn SR, Bates S, McDonald S, Khurana R, et al. Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial. Thromb Res. 2016 Jun;142:17–20.
Rodger, Marc A., et al. “Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial.Thromb Res, vol. 142, June 2016, pp. 17–20. Pubmed, doi:10.1016/j.thromres.2016.04.004.
Rodger MA, Phillips P, Kahn SR, Bates S, McDonald S, Khurana R, James AH, Konkle BA, PROSPER Investigators: Tim Ramsay, Dean Fergusson, Anne McLeod, Wee Shian Chan, Rshmi Khurana, Kara Narenberg, Haim Abenhaim, John Heit, Ghada Bourjeilly, Paul Gibson, Kent Bailey. Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial. Thromb Res. 2016 Jun;142:17–20.
Journal cover image

Published In

Thromb Res

DOI

EISSN

1879-2472

Publication Date

June 2016

Volume

142

Start / End Page

17 / 20

Location

United States

Related Subject Headings

  • Venous Thromboembolism
  • Postpartum Period
  • Pilot Projects
  • Humans
  • Heparin, Low-Molecular-Weight
  • Female
  • Cardiovascular System & Hematology
  • Anticoagulants
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology